Extendicare Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was CAD 308.89 million compared to CAD 284.27 million a year ago. Net loss was CAD 4.27 million compared to net income of CAD 6.04 million a year ago. Basic loss per share from continuing operations was CAD 0.04 compared to basic earnings per share from continuing operations of CAD 0.03 a year ago. Diluted loss per share from continuing operations was CAD 0.04 compared to diluted earnings per share from continuing operations of CAD 0.03 a year ago. Basic loss per share was CAD 0.04 compared to basic earnings per share of CAD 0.07 a year ago. Diluted loss per share was CAD 0.04 compared to diluted earnings per share of CAD 0.07 a year ago.
For the nine months, sales was CAD 911.18 million compared to CAD 860.83 million a year ago. Net income was CAD 71.25 million compared to CAD 15.33 million a year ago. Basic earnings per share from continuing operations was CAD 0.04 compared to CAD 0.13 a year ago. Diluted earnings per share from continuing operations was CAD 0.04 compared to CAD 0.13 a year ago. Basic earnings per share was CAD 0.79 compared to CAD 0.17 a year ago.